tradingkey.logo

Helius Medical Technologies Inc

HSDT
View Detailed Chart

4.750USD

+4.489+1726.22%
Close 05/02, 16:00ETQuotes delayed by 15 min
29.10MMarket Cap
LossP/E TTM

Helius Medical Technologies Inc

4.750

+4.489+1726.22%
Intraday
1m
30m
1h
D
W
M
D

Today

+1726.22%

5 Days

+1526.71%

1 Month

+1058.54%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
HOLD
Current Rating
0.000
Target Price
0.00%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Helius Medical Technologies Inc
HSDT
1
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Intuitive Surgical Inc
ISRG
33
Thermo Fisher Scientific Inc
TMO
33
Veeva Systems Inc
VEEV
32
1
2
3
...
18

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(0)
Neutral(0)
Buy(2)
Indicators
Sell(0)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
--
--
RSI(14)
--
--
STOCH(KDJ)(9,3,3)
--
--
ATR(14)
--
--
CCI(14)
--
--
Williams %R
--
--
TRIX(12,20)
--
--
StochRSI(14)
--
--
Moving Average
Sell(0)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
--
--
MA10
--
--
MA20
--
--
MA50
--
--
MA100
--
--
MA200
--
--

News

More news coming soon, stay tuned...

Company

Helius Medical Technologies, Inc. is a neurotechnology company. The Company is engaged in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS), is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy utilizes the PoNS device in conjunction with supervised therapeutic exercise. The PoNS Therapy consists of condition-specific exercises for movement control, including balance and gait training and breathing and awareness training, which are tailored to focus on the individual patient’s functional deficits.
Company codeHSDT
CompanyHelius Medical Technologies Inc
CEOMr. Dane C. Andreeff
Websitehttps://heliusmedical.com/